{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:22:15Z","timestamp":1780676535119,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T00:00:00Z","timestamp":1622160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ijid.2021.05.071","type":"journal-article","created":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T23:59:35Z","timestamp":1622678375000},"page":"517-521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Inverse association between hypertension treatment and COVID-19 prevalence in Japan"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9690-3014","authenticated-orcid":false,"given":"Masako","family":"Kinoshita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balachandar","family":"Vellingiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4361-5454","authenticated-orcid":false,"given":"Shawn J.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2021.05.071_bib0005","article-title":"The association of renin-angiotensin-aldosterone system inhibitors with outcomes among a predominantly ethnic minority patient population hospitalized with COVID-19: the Bronx experience","volume":"12","author":"Adrish","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.ijid.2021.05.071_bib0010","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019669","article-title":"Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers use and COVID-19 infection among 824 650 patients with hypertension from a US integrated healthcare system","volume":"10","author":"An","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ijid.2021.05.071_bib0015","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11883-020-00880-6","article-title":"Effect of renin-angiotensin-aldosterone system inhibitors in patients with COVID-19: a systematic review and meta- analysis of 28,872 patients","volume":"22","author":"Baral","year":"2020","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.ijid.2021.05.071_bib0020","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.stemcr.2021.02.010","article-title":"Common genetic variation in humans impacts in vitro susceptibility to SARS-CoV2 infection","volume":"16","author":"Dobrindt","year":"2021","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.ijid.2021.05.071_bib0025","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ijid.2021.05.071_bib0030","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1038\/nn.4399","article-title":"Gene expression elucidates functional impact of polygenic risk for schizophrenia","volume":"19","author":"Fromer","year":"2016","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.ijid.2021.05.071_bib0035","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/ajh\/hpu086","article-title":"Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker","volume":"28","author":"Furuhashi","year":"2015","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ijid.2021.05.071_bib0040","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0165-2478(94)00158-8","article-title":"Nitric oxide: cytokine-regulation of nitric oxide in host resistance to intracellular pathogens","volume":"43","author":"Green","year":"1994","journal-title":"Immunol Lett"},{"key":"10.1016\/j.ijid.2021.05.071_bib0045","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nm0695-515","article-title":"Nitric oxide in mucosal immunity","volume":"1","author":"Green","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.ijid.2021.05.071_bib0050","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.micinf.2020.05.006","article-title":"Covid-19 accelerates endothelial dysfunction and nitric oxide deficiency","volume":"22","author":"Green","year":"2020","journal-title":"Microbes Infect"},{"key":"10.1016\/j.ijid.2021.05.071_bib0055","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s40256-020-00439-5","article-title":"Mortality and disease severity among COVID-19 patients receiving renin-angiotensin system inhibitors: a systematic review and meta-analysis","volume":"20","author":"Hasan","year":"2020","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.ijid.2021.05.071_bib0060","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.immuni.2020.04.003","article-title":"COVID-19: a new virus, but a familiar receptor and cytokine release syndrome","volume":"52","author":"Hirano","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.ijid.2021.05.071_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ijid.2021.05.071_bib0070","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.schres.2018.02.040","article-title":"Schizophrenia-associated rs4702 G allele-specific downregulation of FURIN expression by miR-338-3p reduces BDNF production","volume":"199","author":"Hou","year":"2018","journal-title":"Schizophr Res"},{"key":"10.1016\/j.ijid.2021.05.071_bib0075","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2021.05.071_bib0080","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/ggi.13276","article-title":"Current use of antihypertensive drugs in Japanese patients with hypertension: analysis by age group","volume":"18","author":"Ishida","year":"2018","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.ijid.2021.05.071_bib0085","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/jama.1981.03310370017013","article-title":"Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham study","volume":"245","author":"Kannel","year":"1981","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2021.05.071_bib0090","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jinf.2020.08.013","article-title":"Impact of routine infant BCG vaccination on COVID-19","volume":"81","author":"Kinoshita","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2021.05.071_bib0095","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/s41440-020-00535-8","article-title":"Renin- angiotensin system inhibitors and the severity of coronavirus disease 2019 in Kanagawa, Japan: a retrospective cohort study","volume":"43","author":"Matsuzawa","year":"2020","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ijid.2021.05.071_bib0100","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","article-title":"Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension","volume":"9","author":"Meng","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.ijid.2021.05.071_bib0105","series-title":"About coronavirus disease 2019 (COVID-19)","author":"Ministry of Health, Labour and Welfare of Japan","year":"2020"},{"key":"10.1016\/j.ijid.2021.05.071_bib0110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11010-008-9905-3","article-title":"Comparison of vasopeptidase inhibitor omapatrilat and angiotensin receptor blocker candesartan on extracellular matrix, myeloperoxidase, cytokines, and ventricular remodeling during healing after reperfused myocardial infarction","volume":"321","author":"Palaniyappan","year":"2009","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.ijid.2021.05.071_bib0115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1074-7613(00)80003-5","article-title":"An antiviral mechanism of nitric oxide: inhibition of a viral protease","volume":"10","author":"Saura","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.ijid.2021.05.071_bib0120","first-page":"21","article-title":"Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19","volume":"24","author":"\u015eenkal","year":"2020","journal-title":"Anatol J Cardiol"},{"key":"10.1016\/j.ijid.2021.05.071_bib0125","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/ajh\/hpaa057","article-title":"Hypertension and COVID-19","volume":"33","author":"Schiffrin","year":"2020","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ijid.2021.05.071_bib0130","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/s41588-019-0497-5","article-title":"Synergistic effects of common schizophrenia risk variants","volume":"51","author":"Schrode","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.ijid.2021.05.071_bib0135","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/s41440-020-0515-0","article-title":"Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19","volume":"43","author":"Shibata","year":"2020","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ijid.2021.05.071_bib0140","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1128\/JVI.02062-10","article-title":"A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry","volume":"85","author":"Shulla","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.ijid.2021.05.071_bib0145","unstructured":"SNPedia, rs4702. https:\/\/www.snpedia.com\/index.php\/Rs4702. [Accessed 26 September 2020]."},{"key":"10.1016\/j.ijid.2021.05.071_bib0150","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.niox.2009.10.007","article-title":"Dietary nitrate in Japanese traditional foods lowers diastolic blood pressure in healthy volunteers","volume":"22","author":"Sobko","year":"2010","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.ijid.2021.05.071_bib0155","series-title":"e-Stat, Portal Site of Official Statistics of Japan","author":"Statistics Bureau, Ministry of Internal Affairs and Communications of Japan","year":"2020"},{"key":"10.1016\/j.ijid.2021.05.071_bib0160","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/01.STR.13.1.62","article-title":"Risk factors for cerebral hemorrhage and cerebral infarction in a Japanese rural community","volume":"13","author":"Tanaka","year":"1982","journal-title":"Stroke"},{"key":"10.1016\/j.ijid.2021.05.071_bib0165","series-title":"Japanese Guidelines for the Management of Stroke 2015, Revised","author":"The Japan Stroke Society","year":"2019"},{"key":"10.1016\/j.ijid.2021.05.071_bib0170","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/HJH.0000000000000378","article-title":"Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials","volume":"32","author":"Thomopoulos","year":"2014","journal-title":"J Hypertens"},{"key":"10.1016\/j.ijid.2021.05.071_bib0175","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"issue":"1_suppl","key":"10.1016\/j.ijid.2021.05.071_bib0180","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1177\/14703203010020011101","article-title":"Improvement of endothelial dysfunction in experimental heart failure by chronic RAAS-blockade: ACE-inhibition or AT1-receptor blockade?","volume":"2","author":"Wagenaar","year":"2001","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.ijid.2021.05.071_bib0185","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ijid.2021.05.071_bib0190","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.niox.2020.07.005","article-title":"Blood nitrate and nitrite modulating nitric oxide bioavailability: potential therapeutic functions in COVID-19","volume":"103","author":"Yamasaki","year":"2020","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.ijid.2021.05.071_bib0195","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2021.05.071_bib0200","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221004744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221004744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:02:15Z","timestamp":1761120135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971221004744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":40,"alternative-id":["S1201971221004744"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2021.05.071","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inverse association between hypertension treatment and COVID-19 prevalence in Japan","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2021.05.071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}